Multigenic and imprinting control of ovarian granulosa cell tumorigenesis in mice

Cancer Research

Volumn 58, Issue 16, 1998, Pages 3694-3699

  Beamer, Wesley G ^a   Shultz, Kathryn L ^a   Tennent, Barbara J ^a   Nadeau, Joseph H ^b   Churchill, Gary A ^a   Eicher, Eva M ^a  

^a JACKSON LABORATORY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ALLELE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GRANULOSA CELL; HETEROZYGOSITY LOSS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGENY;

ALLELES; ANIMALS; CROSSES, GENETIC; DISEASE SUSCEPTIBILITY; FEMALE; GENETIC MARKERS; GENOTYPE; GRANULOSA CELL TUMOR; LOGISTIC MODELS; MICE; OVARIAN NEOPLASMS; SPECIES SPECIFICITY;

EID: 0032529442     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Beamer, W. G., Hoppe, P. C., and Whitten, W. K. Spontaneous malignant granulosa cell tumors in ovaries of young SWR mice. Cancer Res., 45: 5575-5581, 1985.
2. Beamer, W. G. Gonadotropin, steroid, and thyroid hormone milieu of young SWR mice bearing spontaneous granulosa cell tumors. J. Natl. Cancer Inst., 77: 1117-1123, 1986.
3. Tennent, B. J., Shultz, K. L., Sundberg, J. P., and Beamer, W. G. Preneoplastic, primary, and metastatic ovarian granulosa cell tumors in a novel SWR-derived F1 hybrid mouse stock. Am. J. Obstet. Gynecol., 163: 625-634, 1990.
4. Beamer, W. G., Shultz, K. L., Tennent, B. J., and Shultz, L. D. Granulosa cell tumorigenesis in genetically hypogonadal-immunodeficient mice grafted with ovaries from tumor susceptible donors. Cancer Res., 53: 3741-3746, 1993.
5. Scully, R. E. Ovarian tumors. A review. Am. J. Pathol., 87: 686-720, 1977.
6. Lock, E. E., Perez, A. R., Atayde, M. D., Murphy, A. S. K., Goldstein, D. P., Crigler, J. F., and Vawter, G. F. Granulosa-theca cell tumors in premenarchal girls: a clinical and pathological study of ten cases. Cancer (Phila.), 48: 1846-1854, 1981.
7. Fox, H. Sex cord-stromal tumours of the ovary. J. Pathol., 145: 127-148, 1985.
8. Young, R. H., Dickersin, G. R., and Scully, R. E. Juvenile granulosa cell tumor of the ovary. Am. J. Surg. Pathol., 8: 575-596, 1984.
9. Beamer, W. G., Shultz, K. L., and Tennent, B. J. Induction of ovarian granulosa cell tumors in SWXJ-9 mice with dehydroepiandrosterone. Cancer Res., 48: 2788-2792, 1988.
10. Beamer, W. G., Tennent, B. J., Shultz, K. L., Shultz, L. D., Nadeau, J. D., and Skow, L. C. Gene for ovarian granulosa cell tumor susceptibility, Gct, in SWXJ recombinant inbred strains of mice revealed by dehydroepiandrosterone. Cancer Res., 48: 5092-5095, 1988.
11. Tennent, B. J., Shultz, K. L., and Beamer, W. G. Genetic susceptibility for C19 androgen induction of ovarian granulosa cell tumorigenesis in SWXJ strains of mice. Cancer Res., 53: 1059-1063, 1993.
12. Svenson, K. L., Cheah, Y-C., Shultz, K. L., Mu, J-L., Paigen, B., and Beamer, W. G. Strain distribution pattern for the SSLP markers in the SWXJ recombinant inbred strain set: chromosomes 1 to 6. Mamm. Genome, 6: 867-872, 1995.
13. Shultz, K. L., Svenson, K. L., Cheah, Y-C., Paigen. B., and Beamer, W. G. Strain distribution pattern for SSLP markers in the SWXJ recombinant inbred strain set: chromosomes 7 to X. Mamm. Genome, 7: 526-532, 1996.
14. Breslow, N., and Day, N. E. Statistical Methods in Cancer Research: The Analysis of Case Control Studies, Vol. 1. Lyon, France: IARC, 1980.
15. Lander, E., and Kruglyak, L. Genetic dissection of complex traits: guidelines for interpreting and reporting results. Nat. Genet., 11: 241-247, 1995.
16. Bailey, D. W. Recombinant inbred strains and bilineal congenic strains. In: H. L. Foster, J. D. Small, and J. G. Fox (eds.), The Mouse in Biomedical Research. I. History, Genetics, and Wild Mice., pp. 223-240. New York: Academic Press, 1981.
17. Lasko, D., Cavenee, W., and Nordenskkjold, M. Loss of constitutional heterozygosity in human cancer. Annu. Rev. Genet., 25: 281-314, 1991.
18. de Souza, A. T., Yamada, T., Mills, J. J., and Jirtle, R. L. Imprinted genes in liver carcinogenesis. FASEB J., 11: 60-67, 1997.
19. Brown, C. A gene from the region of the human X inactivation centre expressed exclusively from the inactive X chromosome. Nature (Lond.), 349: 38-44, 1991.
20. Marahrens, Y., Panning, B., Dausman, J., Strauss, W., and Jaenisch, R. Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes Dev., 11: 156-166, 1997.
21. Peterson, K., and Sapienza, C. Imprinting the genome: imprinted genes, imprinting genes, and a hypothesis for their interaction. Annu. Rev. Genet., 27: 7-31, 1993.
22. Montagutelli, X., Turner, R., and Nadeau, J. H. Epistatic control of non-Mendelian inheritance in mouse interspecific crosses. Genetics, 143: 1739-1752, 1996.
23. Quaderi, N. A., Meehan, R., Tate, P. H., Cross, S. H., Bird, A. P., Chatterjee, A., Herman, G. E., and Brown, S. Genetic and physical mapping of a gene encoding a methyl CpG binding protein, Mecp2, to the mouse X chromosome. Genomics, 22: 648-651, 1994.
24. Rastan, S., and Cattanach, B. Interaction between the Xce locus and imprinting of the paternal X chromosome in mouse yolk-sac endoderm. Nature (Lond.), 303: 635-637, 1983.
25. n repeats. Mamm. Genome, 4: 523-530, 1993.
26. Blake, J. A., Richardson, J. E., Davisson, M. T., Eppig, J. T., and The Mouse Genome Informatics Group. The Mouse Genome Database (MGD). A comprehensive public resource of genetic, phenotypic and genomic data. Nucleic Acids Res., 25: 85-91, 1997.
27. Gariboldi, M., Manenti, G., Canzian, F., Falvella, F. S., Pierotti, M. A., Della Porta, G., Binelli, G., and Dragani, T. A. Chromosome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res., 53: 209-211, 1993.
28. Bennett, L. M., Winkler, M. L., and Drinkwater, N. R. A gene that determines the high susceptibility of the C3H/HeJ strain of mouse to liver tumor induction is located on chromosome one. Proc. Am. Assoc. Cancer Res., 34: 144, 1993.
29. Manenti, G., Binelli, G., Gariboldi, M., Canzian, F., De Gregorio, L., Falvella, F. S., Dragani, T. A., and Pierotti, M. A. Multiple loci affect genetic predisposition to hepatocarcinogenesis in mice. Genomics, 23: 118-124, 1994.
30. Lee, G. H., Bennett, L. M., Carabeo, R. A., and Drinkwater, N. R. Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics, 139: 387-395, 1995.
31. Poole, T. M., and Drinkwater, N. R. Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones. Proc. Natl. Acad. Sci. USA, 93: 5848-5853, 1996.
32. Fijneman, R. J. A., de Vries, S. S., Jansen, R. C., and Demant, P. Complex interactions of new quantitative Irait loci, Slucl, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat. Genet., 14: 465-467, 1996.
33. van Wezel, T., Stassen, A. P. M., Moen, C. J. A., Hart, A. A. M., van der Valk, M. A., and Demant, P. Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat. Genet., 14: 468-470, 1996.
34. Nusse, R., and Berns, A. Cellular oncogene activation by insertion of retroviral DNA; genes identified by provirus tagging. In: G. Klein (ed.), Cellular Oncogene Activation, pp. 95-113. New York: Marcel Dekker, Inc., 1988.